000 | 01328 a2200397 4500 | ||
---|---|---|---|
005 | 20250512005725.0 | ||
264 | 0 | _c19890823 | |
008 | 198908s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMokyr, M B | |
245 | 0 | 0 |
_aImportance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor. _h[electronic resource] |
260 |
_bCancer research _cAug 1989 |
||
300 |
_a4597-606 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Surface _ximmunology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aIsoantibodies |
650 | 0 | 4 | _aLymphocyte Depletion |
650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aPlasmacytoma _xchemically induced |
650 | 0 | 4 |
_aSpleen _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes _xclassification |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 | _aThy-1 Antigens |
700 | 1 | _aBarker, E | |
700 | 1 | _aWeiskirch, L M | |
700 | 1 | _aTakesue, B Y | |
700 | 1 | _aPyle, J M | |
773 | 0 |
_tCancer research _gvol. 49 _gno. 16 _gp. 4597-606 |
|
999 |
_c2574117 _d2574117 |